TrialMedicine2017

The minimal effective dose of cis-9-cetylmyristoleate (CMO) in persons presenting with knee joint pain: A double-blind, randomized, placebo-controlled trial.

Sang Chul Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.